ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

PTGX Protagonist Therapeutics Inc

36.88
0.00 (0.00%)
Pre Market
Last Updated: 09:29:29
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0000060M254.95M4.17M
Operating Income -32.3M-36.52M-36.02M-42.35M-38.33M23.05M206.31M-38.79M
Pre Tax Income -31.23M-34.19M-33.73M-38.46M-34.11M27.34M210.67M-31.29M
Net Income -31.23M-34.19M-33.73M-38.46M-34.11M27.34M207.34M-30.62M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -32.39M-36.45M-36.22M-42.37M-38.36M23.09M206.29M-38.7M
EBITDA -32.03M-36.26M-35.77M-42.12M-38.08M23.3M206.55M-38.55M
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 020.06M30.93M231k28.63M27.36M26.58M60M
Operating Income -32.67M-37.9M-42.27M-80.52M-64.52M-125.85M-131.37M-93.65M
Pre Tax Income -37.18M-36.96M-39.72M-77.88M-64.85M-125.55M-127.39M-78.96M
Net Income -37.74M-36.96M-38.92M-77.19M-66.15M-125.55M-127.39M-78.96M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -2.257-1.753-1.679-2.836-1.512-2.625-2.582-1.369
EBIT -32.7M-37.9M-42.27M-80.52M-65.15M-125.99M-131.45M-93.85M
EBITDA -32.35M-37.49M-41.74M-79.82M-63.73M-125.03M-130.34M-92.68M